CY1109001T1 - Kappa-like Fighters in the Treatment of Cystic Diseases - Google Patents
Kappa-like Fighters in the Treatment of Cystic DiseasesInfo
- Publication number
- CY1109001T1 CY1109001T1 CY20071101231T CY071101231T CY1109001T1 CY 1109001 T1 CY1109001 T1 CY 1109001T1 CY 20071101231 T CY20071101231 T CY 20071101231T CY 071101231 T CY071101231 T CY 071101231T CY 1109001 T1 CY1109001 T1 CY 1109001T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- fighters
- kappa
- cystic diseases
- medicament
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 206010005052 Bladder irritation Diseases 0.000 abstract 1
- -1 [(1S) -1-phenyl-2 - ((3S) -3-hydroxypyrrolidin-1-yl) ethyl] -2,2-biphenyl acetamide Chemical compound 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000026533 urinary bladder disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η ευρεσιτεχνία αφορά τη χρήση του φαρμάκου Ν-μεθυλο-Ν[(1S)-1-φαινυλο-2-((3S)-3-υδροξυπυρρολιδιν-1-υλο)αιθυλο]-2,2-διφαινυλο-ακεταμίδιο ή ενός από τα φαρμακολογικά αποδεκτά άλατά του με σκοπό τη παρασκευή ενός φαρμακευτικού σκευάσματος για τη θεραπεία των παθήσεων της κύστης, ιδιαίτερα της ερεθισμένης κύστης και των πόνων που συνδέονται με αύτή.The invention relates to the use of the medicament N-methyl-N [(1S) -1-phenyl-2 - ((3S) -3-hydroxypyrrolidin-1-yl) ethyl] -2,2-biphenyl acetamide or one of the pharmacologically acceptable salts thereof for the preparation of a medicament for the treatment of bladder diseases, in particular irritable bladder and associated pain.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10116978A DE10116978A1 (en) | 2001-04-05 | 2001-04-05 | Kappa opiate agonists for the treatment of diseases of the bladder |
| EP02724228A EP1397128B1 (en) | 2001-04-05 | 2002-03-13 | Kappa opoid agonist for the treatment of irritable bladder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109001T1 true CY1109001T1 (en) | 2014-07-02 |
Family
ID=7680492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071101231T CY1109001T1 (en) | 2001-04-05 | 2007-09-25 | Kappa-like Fighters in the Treatment of Cystic Diseases |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20040157913A1 (en) |
| EP (2) | EP1834640A3 (en) |
| JP (1) | JP2004525165A (en) |
| KR (1) | KR100851938B1 (en) |
| CN (1) | CN1268332C (en) |
| AT (1) | ATE366109T1 (en) |
| AU (1) | AU2002254947B2 (en) |
| BR (1) | BR0208488A (en) |
| CA (1) | CA2443019C (en) |
| CY (1) | CY1109001T1 (en) |
| CZ (1) | CZ20032899A3 (en) |
| DE (2) | DE10116978A1 (en) |
| DK (1) | DK1397128T3 (en) |
| ES (1) | ES2290286T3 (en) |
| HU (1) | HUP0303910A3 (en) |
| MX (1) | MXPA03009099A (en) |
| MY (1) | MY136683A (en) |
| PL (1) | PL363540A1 (en) |
| PT (1) | PT1397128E (en) |
| RU (1) | RU2307651C2 (en) |
| SK (1) | SK13272003A3 (en) |
| WO (1) | WO2002080905A1 (en) |
| ZA (1) | ZA200308600B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10259245A1 (en) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | Derivatives of asimadolin with covalently bound acids |
| WO2005046687A1 (en) * | 2003-10-30 | 2005-05-26 | Tioga Pharmaceuticals, Inc. | Use of selective opiate receptor modulators in the treatment of neuropathy |
| PT2136801E (en) | 2007-03-30 | 2012-12-06 | Tioga Pharmaceuticals Inc | Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome |
| BR112014020271A8 (en) * | 2012-03-19 | 2017-07-11 | Wellesley Pharmaceuticals Llc | PHARMACEUTICAL COMPOSITION AND METHODS TO DECREASE URINATION FREQUENCY IN PATIENTS |
| US8637538B1 (en) | 2012-12-14 | 2014-01-28 | Trevi Therapeutics, Inc. | Methods for treatment of pruritis |
| US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| US8987289B2 (en) | 2012-12-14 | 2015-03-24 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| CN112703000B (en) | 2018-07-23 | 2024-05-31 | 特雷维治疗股份有限公司 | Treatment of chronic cough, shortness of breath, and difficulty breathing |
| AU2021206252A1 (en) | 2020-01-10 | 2022-07-28 | Trevi Therapeutics, Inc. | Methods of administering nalbuphine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6A (en) * | 1836-08-10 | Thomas Blanchard | Machine for forming end pieces of plank blocks for ships | |
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| DE4215213A1 (en) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
| CA2099233A1 (en) * | 1992-06-29 | 1993-12-30 | Conrad P. Dorn | Morpholine and thiomorpholine tachykinin receptor antagonists |
| DE19523502A1 (en) * | 1995-06-28 | 1997-01-02 | Merck Patent Gmbh | Kappa opiate agonists for inflammatory bowel diseases |
| DE19531464A1 (en) * | 1995-08-26 | 1997-02-27 | Merck Patent Gmbh | N-methyl-N - [(1S -) - 1-phenyl-2 - ((3S) -3-hydroxypyrrolidin 1-yl -) - ethyl] -2,2-diphenyl-acetamide |
| US5859043A (en) * | 1996-06-11 | 1999-01-12 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Method for maintaining kidney function during surgery or severe trauma under general anesthesia |
| US6201022B1 (en) * | 1997-03-27 | 2001-03-13 | Myorx, Inc. | Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid |
| US5965701A (en) | 1997-12-23 | 1999-10-12 | Ferring Bv | Kappa receptor opioid peptides |
-
2001
- 2001-04-05 DE DE10116978A patent/DE10116978A1/en not_active Withdrawn
-
2002
- 2002-03-13 US US10/474,312 patent/US20040157913A1/en not_active Abandoned
- 2002-03-13 SK SK1327-2003A patent/SK13272003A3/en not_active Application Discontinuation
- 2002-03-13 MX MXPA03009099A patent/MXPA03009099A/en active IP Right Grant
- 2002-03-13 EP EP07111669A patent/EP1834640A3/en not_active Withdrawn
- 2002-03-13 AT AT02724228T patent/ATE366109T1/en active
- 2002-03-13 KR KR1020037012331A patent/KR100851938B1/en not_active Expired - Fee Related
- 2002-03-13 JP JP2002578944A patent/JP2004525165A/en active Pending
- 2002-03-13 PT PT02724228T patent/PT1397128E/en unknown
- 2002-03-13 BR BR0208488-0A patent/BR0208488A/en not_active IP Right Cessation
- 2002-03-13 ES ES02724228T patent/ES2290286T3/en not_active Expired - Lifetime
- 2002-03-13 RU RU2003130641/14A patent/RU2307651C2/en active
- 2002-03-13 HU HU0303910A patent/HUP0303910A3/en unknown
- 2002-03-13 DK DK02724228T patent/DK1397128T3/en active
- 2002-03-13 CN CNB028073983A patent/CN1268332C/en not_active Expired - Fee Related
- 2002-03-13 CA CA002443019A patent/CA2443019C/en not_active Expired - Fee Related
- 2002-03-13 WO PCT/EP2002/002756 patent/WO2002080905A1/en not_active Ceased
- 2002-03-13 EP EP02724228A patent/EP1397128B1/en not_active Expired - Lifetime
- 2002-03-13 DE DE50210422T patent/DE50210422D1/en not_active Expired - Lifetime
- 2002-03-13 CZ CZ20032899A patent/CZ20032899A3/en unknown
- 2002-03-13 PL PL02363540A patent/PL363540A1/en unknown
- 2002-03-13 AU AU2002254947A patent/AU2002254947B2/en not_active Ceased
- 2002-04-02 MY MYPI20021192A patent/MY136683A/en unknown
-
2003
- 2003-11-04 ZA ZA200308600A patent/ZA200308600B/en unknown
-
2007
- 2007-09-25 CY CY20071101231T patent/CY1109001T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL363540A1 (en) | 2004-11-29 |
| MXPA03009099A (en) | 2004-02-12 |
| ZA200308600B (en) | 2004-09-13 |
| CA2443019A1 (en) | 2002-10-17 |
| SK13272003A3 (en) | 2004-02-03 |
| EP1834640A2 (en) | 2007-09-19 |
| CA2443019C (en) | 2009-12-29 |
| US20040157913A1 (en) | 2004-08-12 |
| EP1397128B1 (en) | 2007-07-04 |
| HUP0303910A3 (en) | 2005-04-28 |
| ATE366109T1 (en) | 2007-07-15 |
| RU2003130641A (en) | 2005-03-10 |
| DE10116978A1 (en) | 2002-10-10 |
| DK1397128T3 (en) | 2007-10-15 |
| AU2002254947B2 (en) | 2007-06-07 |
| RU2307651C2 (en) | 2007-10-10 |
| DE50210422D1 (en) | 2007-08-16 |
| EP1397128A1 (en) | 2004-03-17 |
| HK1064036A1 (en) | 2005-01-21 |
| MY136683A (en) | 2008-11-28 |
| JP2004525165A (en) | 2004-08-19 |
| CN1499967A (en) | 2004-05-26 |
| CZ20032899A3 (en) | 2004-06-16 |
| EP1834640A3 (en) | 2009-12-23 |
| CN1268332C (en) | 2006-08-09 |
| KR20040025909A (en) | 2004-03-26 |
| PT1397128E (en) | 2007-09-03 |
| ES2290286T3 (en) | 2008-02-16 |
| WO2002080905A1 (en) | 2002-10-17 |
| KR100851938B1 (en) | 2008-08-12 |
| HUP0303910A2 (en) | 2004-03-29 |
| BR0208488A (en) | 2004-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109001T1 (en) | Kappa-like Fighters in the Treatment of Cystic Diseases | |
| CY1109119T1 (en) | PHARMACEUTICAL FORMS OF LONG-TERM RELEASE INCLUDING LAMOTRIGIN | |
| CY1110019T1 (en) | Combined Therapy with Substituted Oxazolidinones | |
| CY1107838T1 (en) | ADAMANTANIUM PRODUCTION FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOGRAPHIC DISEASES | |
| CY1116693T1 (en) | A combination of azelastin and cycloneside | |
| EA200101156A1 (en) | DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC | |
| PT1333887E (en) | METHOD OF TREATMENT OF MUSCULAR DISORDERS | |
| TW200505881A (en) | Tri(cyclo) substituted amide compounds | |
| AR032293A1 (en) | PHARMACEUTICAL CASE | |
| DE602004022946D1 (en) | 4-Cyano-pyrazole-3-carboxylic acid amide derivatives, preparation and therapeutic use thereof | |
| DE60336664D1 (en) | NONNUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| NO20065904L (en) | Therapeutic compounds | |
| CY1105941T1 (en) | RARγ-SELECTIVE RETINOID AGENTS FOR THE TREATMENT OF EMPHYSEMA | |
| DE50005529D1 (en) | ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC | |
| DE60307632D1 (en) | PIPERAZINYLACYLPIPERIDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
| ATE262893T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| CY1107231T1 (en) | Substituted 4-Aminocyclohexanol derivatives | |
| CY1107465T1 (en) | MELAGATRANI FOR THERAPEUTIC INFECTION | |
| SE9902597D0 (en) | New use | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| CY1105165T1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND 4-OXOBUTANOIC ACID AND ITS USE FOR THE TREATMENT OF DIABETES | |
| BG105984A (en) | Osanetant in the treatment of mood disorders | |
| CY1105317T1 (en) | USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE | |
| CY1105142T1 (en) | USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE | |
| EA200500175A1 (en) | SALT MORFIN-6-GLUCURONIDE |